Ameliorative Effect of Empagliflozin and Linagliptin on Cisplatin-Induced Nephrotoxicity and Cardiotoxicity by Reducing Oxidative Stress
Drug Design, Development and Therapy · 2025-12 · Volume 19 · 11483-11497
DOI: 10.2147/dddt.s561268 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025-12. Verfasst von Malak Salah Alharbi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah, Kingdom of Saudi Arabia. Hauptthemen laut MEDLINE: Cisplatin, Linagliptin, Oxidative Stress, Glucosides. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah, Kingdom of Saudi Arabia.
Zitieren
APA
Alharbi, M. S., & Aldubayan, M. A. (2025). Ameliorative Effect of Empagliflozin and Linagliptin on Cisplatin-Induced Nephrotoxicity and Cardiotoxicity by Reducing Oxidative Stress. Drug Design, Development and Therapy, Volume 19, 11483-11497. https://doi.org/10.2147/dddt.s561268
Vancouver
Alharbi MS, Aldubayan MA. Ameliorative Effect of Empagliflozin and Linagliptin on Cisplatin-Induced Nephrotoxicity and Cardiotoxicity by Reducing Oxidative Stress. Drug Design, Development and Therapy. 2025;Volume 19:11483-11497. doi:10.2147/dddt.s561268
BibTeX
@article{Alharbi2025,
author = {Alharbi, Malak Salah and Aldubayan, Maha Abdulrahman},
title = {Ameliorative Effect of Empagliflozin and Linagliptin on Cisplatin-Induced Nephrotoxicity and Cardiotoxicity by Reducing Oxidative Stress},
journal = {Drug Design, Development and Therapy},
year = {2025},
volume = {Volume 19},
pages = {11483--11497},
doi = {10.2147/dddt.s561268}
}
EUVIMED